(Total Views: 476)
Posted On: 08/18/2020 8:28:44 PM
Post# of 153940
100% agree.
IMO, if I were NP, I’d go almost 100% at cancer. That is a huge indication considering the presence of CCR5 in metastatic cancers and solid tumors (I don’t remember the exact %, but I believe Dr. BP quoted a pretty high % at one point). That would mean increasing the number of sites, increasing enrollment, and possibly starting a few more phase 2 trials for specific cancers, such as prostate cancer or pancreatic cancer. Results from those trials cannot be denied as cancer is and will continue to be a popular topic because cancer is indiscriminate and can kill anyone of any age. Leronlimab has shown the ability to do this and the world needs to see the data.
IMO, if I were NP, I’d go almost 100% at cancer. That is a huge indication considering the presence of CCR5 in metastatic cancers and solid tumors (I don’t remember the exact %, but I believe Dr. BP quoted a pretty high % at one point). That would mean increasing the number of sites, increasing enrollment, and possibly starting a few more phase 2 trials for specific cancers, such as prostate cancer or pancreatic cancer. Results from those trials cannot be denied as cancer is and will continue to be a popular topic because cancer is indiscriminate and can kill anyone of any age. Leronlimab has shown the ability to do this and the world needs to see the data.
(3)
(0)
